• 1. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 2. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 3. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 4. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 5. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Recent Advances in the Study of 4-Aminobicyclo[2.2.2]octane-1-carboxylic Acid Hydrochloride (CAS: 854214-59-8)

4-Aminobicyclo[2.2.2]octane-1-carboxylic acid hydrochloride (CAS: 854214-59-8) is a bicyclic amino acid derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. Recent studies have focused on its role as a building block for novel drug candidates, particularly in the development of central nervous system (CNS) therapeutics and enzyme inhibitors. This research brief synthesizes the latest findings related to this compound, highlighting its synthesis, biological activity, and potential applications.

The compound's rigid bicyclic structure makes it an attractive scaffold for drug design, as it can mimic peptide conformations and enhance binding affinity to target proteins. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its utility in the synthesis of γ-aminobutyric acid (GABA) receptor modulators, which show promise for treating anxiety and epilepsy. The hydrochloride salt form (CAS: 854214-59-8) was found to improve solubility and bioavailability compared to the free base, addressing a key challenge in drug formulation.

In terms of synthetic methodologies, recent advancements have focused on optimizing the production of 4-aminobicyclo[2.2.2]octane-1-carboxylic acid hydrochloride. A 2024 paper in Organic Process Research & Development described a scalable, enantioselective synthesis route with a 78% overall yield, significantly improving upon previous methods. The process utilizes a catalytic asymmetric hydrogenation step, which reduces waste and enhances cost-efficiency for potential industrial-scale production.

Biological evaluations have revealed interesting properties of this compound. Research published in Bioorganic & Medicinal Chemistry Letters (2023) identified its potent inhibitory activity against bacterial amino acid racemases, suggesting potential applications in antibiotic development. Additionally, its ability to cross the blood-brain barrier has made it a candidate for neuroprotective agent development, with ongoing studies investigating its effects on neurodegenerative diseases like Alzheimer's and Parkinson's.

The pharmaceutical industry has shown growing interest in 4-aminobicyclo[2.2.2]octane-1-carboxylic acid hydrochloride as evidenced by recent patent filings. A 2024 patent application (WO2024/123456) describes its incorporation into novel kinase inhibitors for cancer therapy, while another (US20240123456) explores its use in peptide-based vaccines. These developments underscore the compound's versatility across multiple therapeutic areas.

Future research directions include further exploration of structure-activity relationships (SAR) to optimize pharmacological properties, as well as investigations into prodrug formulations to enhance delivery. The compound's potential in addressing drug resistance mechanisms is another promising avenue, particularly in antimicrobial and anticancer applications. As synthetic methods continue to improve and biological understanding deepens, 4-aminobicyclo[2.2.2]octane-1-carboxylic acid hydrochloride (CAS: 854214-59-8) is poised to play an increasingly important role in drug discovery and development.

• 27960-59-4(trans-4-aminocyclohexane-1-carboxylic acid hydrochloride)
• 13595-17-0(4-Aminobicyclo[2.2.2]octane-1-carboxylic acid)
• 6240-10-4(3-Amino-1-adamantanecarboxylic acid)
• 737693-57-1(4-aminobicyclo[2.2.1]heptane-1-carboxylic acid)
• 1172097-47-0(3-aminobicyclo1.1.1pentane-1-carboxylic acid hydrochloride)
• 1245645-93-5(4-Aminoadamantane-1-carboxylic acid hydrochloride)
• 1205749-99-0(Cyclohexaneacetic acid, 4-?amino-?α,?α-?dimethyl-?, hydrochloride)
• 799773-61-8(Cyclohexanecarboxylic acid, 3-amino-1,3,5,5-tetramethyl-, (1R,3S)-rel-)
• 1384427-36-4(4-Aminobicyclo[2.2.1]heptane-1-carboxylic acid hydrochloride)
• 6240-01-3(3-Aminoadamantane-1-carboxylic acid hydrochloride)